Effects of fibroblast growth factors 19 and 20 on cell multiplication and locomotion in a human embryonal carcinoma cell line (Tera-2) in Vitro

Anticancer Research

Volumn 26, Issue 5 A, 2006, Pages 3307-3310

  Engström, Wilhelm ^a   Granerus, Marika ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Cell locomotion; Cell multiplication; Heparin binding growth factors

Indexed keywords

FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR 19; RECOMBINANT FIBROBLAST GROWTH FACTOR 20; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL DIVISION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; EMBRYONAL CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

CARCINOMA, EMBRYONAL; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLAST GROWTH FACTORS; HUMANS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 33750707227     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jeffers M, Shimkets R, Prayaga S, Boldog F, Yang M, Burgess C, Fernandes E, Rittman B, Shimkets J, LaRochelle WJ and Lichtenstein HS: Identification of a novel human fibroblast growth factor and characterisation of its role in carcinogenesis. Cancer Res 61: 3131-3138, 2001.
2. Powers A, MacLeskey S and Wellstein A: Fibroblast growth factors, their receptors and signalling. Endocrin Relat Cancer 7: 165-197, 2000.
3. Granerus M: The Effects of Growth Factors on proliferation, survival and motility in a human embryonal carcinoma derived cell line. PhD-thesis, Swedish University of Agricultural Sciences, 1997.
4. Xie MH, Holcomb I, Deuel B, Dowd P, Huang A, Vagts A, Foster J, Liang J, Brush J, Gu Q, Hillan K, Goddard A and Gurney AL: FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11: 729-735, 1999.
5. Kirikoshi H, Sagara N, Saitoh T, Tanaka K, Sekihara H, Shiokawa K and Katoh M: Molecular cloning and characterisation of human FGF-20 on chromosome 8p21.3-p22. Biochen Biophys Res Commun 274(2): 337-343, 2000.
6. Schofield PN, Granerus M, Lee A, Ekström TJ and Engström W: Concentration dependent modulation of bFGF on multiplication and locomotion of human teratocarcinoma cells. FEBS letters 298: 154-158, 1992.
7. Engström W: Different effects of EGF on locomotion and cell proliferation in a cloned human embryonal carcinoma cell line in vitro. J Cell Sci 86: 47-55, 1986.
8. Granerus M and Engström W: Dual effects of four members of the fibroblast growth factor family on multiplication and motility in human teratocarcinoma cells in vitro. Anticancer Res 20: 3527-3532, 2000.
9. Granerus M and Engström W: Effects of fibroblast growth factor 8, fibroblast growth factor 9 and keratinocyte growth factor on multiplication and locomotion in human teratocarcinoma cells in vitro. Anticancer Res 23: 1313-1316, 2003.
10. Thompson S, Stren PL, Webb M, Walsh FS, Engström W, Evans EP, Shi WK, Hopkins B and Graham CF: Cloned human teratoma cells differentiate into neuron like cells and other cell types in retinoic acid. J Cell Sci 72: 37-65, 1984.
11. Biddle C, Li CH, Schofield PN, tate VE, Hopkins B, Engström W, Huskisson NS and Graham CF: Insulin like growth factors and the multiplication of Tera 2 - a human teratoma derived cell line. J Cell Sci 90: 475-485, 1988.
12. Chamberlain CG and McAvoy JW: Induction of lens fibre differentiation by acidic and basic fibroblast growth factor. Growth Factors 1: 125-134, 1989.
13. McAvoy JW and Chamberlain CG: Basic effects on chick lens epithelial cells differ at different concentrations. Development 107: 221-228, 1989.
14. McAvoy JW and Chamberlain CG: Growth factors in the eye. Prog Growth Fact Res 2: 29-43, 1990.
15. Granerus M and Engstrröm W: Growth Factors in apoptosis. Cell Proliferation 29: 309-314, 1996.
16. Harmer NJ, Pelelgrini L, Chirmagze D, Fernandez-Recio J and Blundell TL: The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry 43: 629-640, 2004.
17. Nakamura T, Mochizuki Y, Kanetake H and Kendsa S: Signals via FGF-receptor 2 regulate migration of endothelial cells. Biochem Biophys Res Comm 289: 801-806, 2001.
18. Johnston CL, Cox HC, Gomm JJ and Coombes RC: bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells; FGF-R4 involvement. Biochem J 306: 609-616, 1995.